MR. DAVID FARRELL WILSON, LCSW
Social Work at Berkeley Pl, Brooklyn, NY

License number
New York R-027340-1
Category
Social Work
Type
Clinical
Address
Address
207 Berkeley Pl FLOOR GROUND, Brooklyn, NY 11217
Phone
(917) 751-3113

Personal information

See more information about DAVID FARRELL WILSON at radaris.com
Name
Address
Phone
David Wilson, age 86
5032 Ridge Rd, Lockport, NY 14094
David Wilson, age 48
496 Henderson Ave, Staten Island, NY 10310
(718) 273-8445
David Wilson
496 Madison Ave Apt 1, Albany, NY 12208
(518) 878-5840
David Wilson, age 57
4949 Bear Rd, Liverpool, NY 13088
David Wilson, age 73
4 Long St, Huntington Station, NY 11746
(631) 427-8437

Professional information

David Wilson Photo 1

David Wilson - Brooklyn, NY

Work:
Morgan Stanley Smith Barney - Purchase, NY
Assistant Vice President, Product Manager - 529 Plans, Offshore Mutual Funds
Citi Smith Barney - New York, NY
Vice President, Product Manager - 529 Plans
Unit Investment Trusts
Assistant Vice President, Product Specialist
JP Morgan Chase Bank - Brooklyn, NY
Fund Administrator/ Accountant
Education:
Clark Atlanta University
Bachelor of Business Administration in Finance & Marketing
Skills:
Product Management, Product Development, Team Player, Detail Oreiented,


David Wilson Photo 2

David Wilson - Brooklyn, NY

Work:
M&Ms Retail Store
SALES ASSOCIATE
Toys R Us - New York, NY
Assistant Manager
Radio City Music Hall - New York, NY Brooklyn Cyclones Professional Baseball Team - Brooklyn, NY
RADIO BOARD OPERATOR
American Specialties Inc. - Brooklyn, NY
Packer
District Council 37, AFSCME - New York, NY
Education:
Brooklyn College Brooklyn - New York, NY
BA in Business Managment
City College of New York New York - New York, NY Kingsborough Community College Brooklyn - New York, NY
A.A. in communications
Skills:
Management, Computer, Telephone, Filing, Costumer Relations


David Wilson Photo 3

David Wilson - Brooklyn, NY

Work:
Nomura Securities International
Associate /AVP OTC Derivatives, Repo, MBS, Equities, Collateral Management
Nomura Securities International - New York, NY
Collateral Management Analyst OTC Derivatives, Repo, MBS, ETFs
Nomura Securities International - New York, NY
Equity Sales Support Middle Office Analyst
Nomura Securities International - New York, NY
Reconciliation Control Operations Analyst
Japan Exchange and Teaching Program (JET) - Kagawa Prefecture, Japan
Assistant Language Teacher
Berkshire Hills Music Academy - South Hadley, MA
Artist Development Manager
Education:
The George Washington University - Washington, DC
Bachelor of Arts
University of Cape Town - Cape Town, Western Cape


David Wilson Photo 4

David Wilson - Brooklyn, NY

Work:
Kingsway Exterminating Company, Inc
Office Manager & Compliance Officer
Kingsway Exterminating Company, Inc - Brooklyn, NY
Customer Service Agent
Kingsway Exterminating Company, Inc - Brooklyn, NY
Field Technician


David F Wilson Photo 5

David F Wilson, Brooklyn NY - LCSW

Specialties:
Social Work, Clinical Social Work
Address:
207 Berkeley Pl, Brooklyn 11217
Languages:
English


David Wilson Photo 6

Cyclic Benzimidazole Derivatives Useful As Anti-Diabetic Agents

US Patent:
8394969, Mar 12, 2013
Filed:
Sep 21, 2009
Appl. No.:
12/563782
Inventors:
Brett C. Bookser - San Diego CA, US
Qun Dang - San Diego CA, US
Tony S. Gibson - San Diego CA, US
Hongjian Jiang - San Diego CA, US
De Michael Chung - Rowland Heights CA, US
Jianming Bao - Princeton NJ, US
Jinlong Jiang - Scotch Plains NJ, US
Andy Kassick - Scotch Plains NJ, US
Ahmet Kekec - Hoboken NJ, US
Ping Lan - Dayton NJ, US
Huagang Lu - Plainsboro NJ, US
Gergely M. Makara - Budapest, HU
F. Anthony Romero - Westfield NJ, US
Iyassu Sebhat - Jersey City NJ, US
David Wilson - Brooklyn NY, US
Dariusz Wodka - Monmouth Junction NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4184, C07D 235/26, C07D 235/28, C07D 235/30
US Classification:
5483064, 514387, 514388
Abstract:
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.